BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18409145)

  • 21. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
    Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
    Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes.
    Liang F; Qu H; Lin Q; Yang Y; Ruan X; Zhang B; Liu Y; Yu C; Zhang H; Fang X; Hao X
    World J Surg Oncol; 2015 Aug; 13():258. PubMed ID: 26311227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
    Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes.
    Zgajnar J; Besic N; Podkrajsek M; Hertl K; Frkovic-Grazio S; Hocevar M
    Eur J Cancer; 2005 Jan; 41(2):244-8. PubMed ID: 15661549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer.
    Veys I; Majjaj S; Salgado R; Noterman D; Schobbens JC; Manouach F; Bourgeois P; Nogaret JM; Larsimont D; Durbecq V
    Breast Cancer Res Treat; 2010 Dec; 124(3):599-605. PubMed ID: 19779817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
    Patel A; D'Alfonso T; Cheng E; Hoda SA
    Am J Surg Pathol; 2017 Nov; 41(11):1499-1505. PubMed ID: 28877063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
    Nakashima K; Kurebayashi J; Sonoo H; Tanaka K; Ikeda M; Shiiki S; Yamamoto Y; Nomura T; Sohda M; Seki M; Miyake A; Moriya T; Sadahira Y; Mimura H; Fukunaga M
    Breast Cancer; 2010; 17(1):17-21. PubMed ID: 19466508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases.
    Carcoforo P; Maestroni U; Querzoli P; Lanzara S; Maravegias K; Feggi L; Soliani G; Basaglia E
    World J Surg; 2006 Sep; 30(9):1653-7. PubMed ID: 16927059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
    Wallwiener CW; Wallwiener M; Kurth RR; Röhm C; Neubauer H; Banys MJ; Staebler A; Schönfisch B; Meuer SC; Giese T; Fehm TN
    Breast Cancer Res Treat; 2011 Dec; 130(3):833-44. PubMed ID: 21858660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.
    Osako T; Iwase T; Kimura K; Yamashita K; Horii R; Yanagisawa A; Akiyama F
    Cancer; 2011 Oct; 117(19):4365-74. PubMed ID: 21437889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.
    Wei S; Bleiweiss IJ; Nagi C; Jaffer S
    Clin Breast Cancer; 2014 Aug; 14(4):280-4. PubMed ID: 24581736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.
    Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L;
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.